Myogen
AcquiredWestminster, United States · Founded 2001
- Headquarters
- Westminster, Colorado
- Employees
- 51–200
- Founded
- 2001
- Business Model
- B2B
- Website
- myogen.com
- Last Round
- Series DAug 2003
- Rounds
- 4
- Acquired by
- GileadOct 2006
About
Myogen was a privately held biopharmaceutical company headquartered in Westminster, Colorado, dedicated to discovering, developing, and commercializing drugs for heart failure and related cardiovascular conditions, including pulmonary arterial hypertension. Founded as a spin-off from the University of Colorado, Myogen advanced two key compounds before being acquired by Gilead Sciences in 2006 for $2.5 billion.
Summary
Myogen is a Biotech company based in Westminster, United States, founded in 2001. Its most recent funding was a Series D round in Aug 2003. Investors include BA Venture Partners, Gilead Sciences and NEA.
Funding History
Oct 2006
Sign up to see all 6 rounds
Series C through Acquisition — per-round amounts, valuations, and who invested in each round.
Investors
Similar Companies
China's leading blood products manufacturer
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Simtra provides pharmaceutical and biotech clients development and manufacturing services for ste...
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/myogen"><img src="https://indexed.vc/api/badge/company/myogen" alt="Myogen on Indexed.vc" width="260" height="76" /></a>